News

You can also see the “How Nucala works” section. These drugs are all used to treat eosinophilic asthma, but Nucala and Dupixent treat other conditions as well. Nucala, Dupixent, and Cinqair ...
Significant associations seen for high blood pressure, diabetes, and stroke. HealthDay News — Microplastic exposure may increase the risk for chronic diseases, according to a study presented at the ...
Sign up for our newsletter to get updates to your inbox, and also receive offers from us, our affiliates and partners. By signing up you agree to our Privacy Policy ...
Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...
A San Diego-based biotech company focused on advancing cell, gene, and mRNA-based therapies. Artis emerged from stealth in April 2025 with the acquisition of Landmark Bio, a prominent cell and gene ...
These tools, harnessing the power of AI algorithms, have changed the way we transform images and videos into cartoon-style representations. From professional designers to casual users, AI cartoonizers ...
In addition to COPD, Dupixent is approved in Japan in certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis and chronic spontaneous ...
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the ...
The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...
Artists take on the clown signal, baby steps, and more From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning ...
Dupixent® has been characterized as a critical growth driver for the company, with strong potential for further expansion. The drug’s efficacy throughout multiple inflammatory conditions as ...